Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 11:00:00 EET | Medi-Globe GmbH | Press release
Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes. Developed through a multi‑year collaboration with IHU Strasbourg, mAI Companion® has received MDR CE Mark certification, becoming the first‑of‑its‑kind AI assistant for pancreatic EUS approved for clinical use in Europe. Addressing One of Medicine’s Toughest Imaging Challenges Pancreatic cancer remains one of the deadliest malignancies worldwide, and early detection can significantly improve survival. EUS provides high‑resolution, close‑up imaging and allows targeted biopsy confirmation—but the technique demands years of experience, and subtle lesions can still be difficult to detect. mAI Companion® functions a